Stay updated on Daratumumab & DLI for Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab & DLI for Relapsed AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page shows a site revision update from v3.3.3 to v3.3.4 in the footer, with no visible changes to study details, eligibility criteria, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:01:28.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Added a Locations section showing the study site in Columbus, Ohio. Removed the previous Ohio Locations entry; page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T13:49:39.000Z thumbnail image
  5. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; no study details appear to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:14.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The bottom notice about government funding and operating status was removed, with no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:13:14.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; only minor formatting adjustments to the study details page, and to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:20:24.000Z thumbnail image
  8. Check
    121 days ago
    Change Detected
    Summary
    Introducing a major update notice and current operating status guidance, along with a new version tag v3.2.0; the old version tag v3.1.0 has been removed.
    Difference
    3%
    Check dated 2025-10-06T07:50:11.000Z thumbnail image

Stay in the know with updates to Daratumumab & DLI for Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.